Purpose: The emulsification of silicone oil (SO) is associated with many complications. In this study, we investigate a new SO solvent, perfluorobutylpentane (F4H5) with 1% by volume of perfluorinated polyethers-polyethylene glycol-perfluorinated polyethers (PFPE-PEG-PFPE) triblock copolymer, for removing emulsified droplets. Methods: An in vitro 3D printed model eye chamber was used to evaluate the efficiency of the three test liquids in removing SO droplets, namely saline, F4H5 and F4H5 with surfactant PFPE-PEG-PFPE. The numbers of SO droplets were quantified using a Coulter Counter. The stability of double emulsion formed was tested with a fluidic device based on electro-coalescence. Two retinal cell lines were used to test the biocompatibility of the liquids. Results: The mean number of droplets remaining in the eye chamber after rinsing with a solution of F4H5 with surfactant was 13 315 AE 4620/ml compared to saline (23 460 AE 7595/ml; p < 0.05). The double emulsion was found to be highly stable. The biocompatibility of F4H5 and the surfactant was similar to that of the saline control. Conclusion: By adding a small amount of surfactant, the resultant F4H5 solution is able to promote double emulsification and remove more SO droplets. Although further in vivo safety studies are necessary before clinical trials, the result of our study suggests that F4H5 with surfactant is a promising Rinsing Solution for removing emulsified droplets. This work therefore translates a wellknown phenomenon in emulsion science to tackle the emulsification problem observed in the routine vitreoretinal surgery.
Introduction
Silicone oil (SO) has been extensively used as an intraocular tamponade to treat eye diseases including complicated retinal detachment (Shah et al. 2008) , proliferative vitreoretinopathy (Van Meurs et al. 1993) , giant retinal tear (Amberesin et al. 2003) and ocular trauma (Cekic & Batman 1998) over the past decades. Silicone oil (SO) has a propensity to emulsify with eye movements (Chan et al. 2011) , and the emulsification of SO is associated with complications including inflammation (Bakri & Ekdawi 2008) , glaucoma (Lin et al. 2005 ) and peri-oil fibrosis including epiretinal membrane formation (Ohira et al. 1991) . Emulsified droplets give rise to symptoms of floaters and can interfere with vision, especially with head-down position as in reading (Dabil et al. 2002) . Therefore, conscientious attempts are made to remove as thoroughly as possible emulsified droplets at the time of surgical removal of SO tamponade. The traditional method of 'triple fluid-air exchange' is acknowledged as not to be effective (Dabil et al. 2002) . The reason for this was not entirely clear. We speculated a reason might be that emulsified droplets are stabilized with surfactant and as such they are amphiphilic. Therefore, these droplets might have a tendency to adhere to surfaces inside the eye, which are largely hydrophilic. Consequently, we published a new strategy for removing emulsification using 'double emulsification' (Chan et al. 2015c ). We demonstrated that using a solution of low-molecularweight silicone oil (LMW-SO) with a small amount of a hydrophobic surfactant, it was possible to remove residual emulsified SO droplets more effectively than repeated rinsing with balanced salt solution (BSS). This solution is capable of entrapping the emulsified SO droplets within larger water droplets, which are in turn dispersed in LMW-SO. This silicone-oil-in-waterin-silicone oil (O/W/O) is regarded as a 'double emulsion'. As a per-operative tool, the exposure of the eye to the Rinsing Solution is only brief. Although using retinal cells with in vitro experiment we have shown that LMW-SO had good short-term biocompatibility, its longerterm tolerance by the eye remains a cause for concern whether any significant amount of the Rinsing Solution be left (Nakamura et al. 1991) . The strategy of the cleaning solution relied on its ability to exit the eye through evaporation. LMW-SO is highly volatile. By leaving the eye with an intraocular air bubble as temporary tamponade, the LMW-SO is so volatile that it would evaporate rapidly. Therefore, any residual LMW-SO should theoretically diffuse down concentration gradient and exit the eye via the bloodstream. However, such strategy might not be completely reliable. Perfluorooctane, which also has a high vapour pressure at body temperature, was found to be retained in the eye in 4% of all patients in a large clinical comparative case series (Loewenstein et al. 2000) . Residual perfluorodecalin was confirmed by quantitative gas chromatography after fluid-air exchange despite meticulous removal (Romano et al. 2014) .
Recently, the semifluorinated alkane F4H5 has received CE mark for use as an intraoperative agent. Of all the semifluorinated alkanes tested, F4H5 has been shown to be the most biocompatible in in vitro and in vivo rabbit studies (Mackiewicz et al. 2007 ). Arguably, its biocompatibility might make a safer choice than LMW-SO as a Rinsing Solution for the eye. Previously, one of us was involved in a randomized trial that showed that F4H5 could be used as a rinse during routine SO removal (Stalmans et al. 2015) . The eyes that received F4H5 had 'borderline significantly less emulsification than those not treated with F4H5'. The quantification of emulsification was only via droplet counting using gonioscopy to examine the angle of the anterior chamber superiorly. With the naked eye and the slit lamp, only large droplets could be seen. We have also recently reported that the majority of droplets in the eyes of patients were 2 lm or less in diameter and that they are too small to be seen by biomicroscopy (Chan et al. 2015a) . The method used to quantify emulsification in the randomized clinical trial was not so sensitive as to detect smaller droplets . Furthermore, it is important to note that the strategy employed in the randomized trial was not that of double emulsification (Stalmans et al. 2015) . F4H5 was simply used to dissolve any residual SO left in the eye during SO removal. F4H5 is highly miscible even with very viscous SO. It has been shown in vitro (Liang et al. 2008; Stappler et al. 2010 ) and clinically (Mackiewicz et al. 2007 ) that F4H5 can dissolve SO adherent to intraocular lenses. Large emulsified SO droplets float, whilst small droplets can be kept suspended by Brownian motion and be evenly distributed within the Aqueous phase. Due to its higher density relative to water, F4H5 (specific gravity = 1.28) would not be expected to come into direct contact with the emulsified droplets. F4H5 is immiscible with water so that there would not be sufficient quantity of F4H5 dissolved into the Aqueous phase to destabilize the SO droplets. Therefore, there is some genuine doubt as to whether F4H5 alone could be effective at removing emulsified SO droplets. On the other hand, should an effective synthesized surfactant that can dissolve in F4H5 be found, F4H5 could potentially form the base liquid for a cleaning agent to entrap droplets with double emulsification.
In this study, we explore the use of F4H5 in combination with a synthesized surfactant for removing emulsified SO droplets by triggering double emulsification. We go on to test the biocompatibility of F4H5 with the surfactant and to explore the feasibility of the solution for clinical use. If a safe and effective agent could be found to remove emulsified droplets, some of the complications associated with emulsification might be preventable. A much thorough removal method of SO would also alleviate many patients of the symptoms of troublesome floaters.
Materials and Methods
Test liquids involved in the study are as follows: 1 Phosphate-buffered saline '1X' (PBS) 2 Perfluorobutylpentane (F4H5; supplied by Fluoron GmbH, Ulm, Germany) 3 One per cent by volume of a synthesized surfactant in F4H5. The surfactant was a perfluorinated PFPE-PEG-PFPE and was synthesized as previously described (Chen et al. 2011 ). This will be referred to as the 'Rinsing Solution'. 4 Bovine serum albumin 0.02% (USB Corporation, Cleveland, OH, USA) in PBS was used to mimic Aqueous fluid in the eye (Zaidi et al. 2010 ). This will be referred to as the 'Aqueous'.
The physical properties of the Rinsing Solution were tested. The shear viscosity and the interfacial tension between the Aqueous and F4H5 and between the Aqueous and the Rinsing Solution were measured by a microfluidic viscometer (microVISC, Rheosense, Inc., San Ramon, CA, USA) and the pendant drop method (Song & Springer 1996a,b) , respectively.
Emulsion of SO droplets in Aqueous
A silicone-oil-in-water (SO/W) emulsion was generated by homogenization (T10 Basic Ultra Turrax Ò , IKA Ò , IKA GmbH, Staufen, Germany) of 1 volume % SO 5000 cSt and 99 volume % of the Aqueous (Chan et al. 2015a) . The homogenization was 'exhaustive' in that care was taken to ensure complete emulsification of the oil. This was achieved using a controlled shear rate (59 660 s À1 ) for 1 min. Based on some previous tests, the emulsion generated using this method was stable .
Eye model chamber
The material and the construction of a model eye chamber using 3D printing have been described previously (Chan et al. 2015c) . In brief, the 3D-model eye chambers were fabricated using a rapid prototyping machine (Objet Eden350V; Stratasys, Eden Prairie, MN, USA). The material used for the 3D-printed models was a transparent material (VeroClear; Stratasys, US). The diameter of the printed eye chamber was 2.5 cm. A 5% bovine serum albumin in PBS was used to coat the inner surface of the 3D-printed eye model to render it hydrophilic in order to mimic the surface property of the structures inside the human eye (Fawcett et al. 1994 ).
Quantification of droplets
The droplets were quantified using a Coulter Counter (Multisizer Ò 4; Beckman Coulter, Brea, CA, USA) previously published by our group (Chan et al. 2015a) . The instrument gives the number and the size of droplets. We chose a probe that gave a measurement range for detecting droplets between 1 and 30 lm in diameter.
The study of the efficacy of the three test liquids of removing emulsified droplet
The method to test the efficacy was previously described (Chan et al. 2015b) . Briefly, the model eye chamber was filled with the stabilized SO/W emulsion (described above) and kept in situ for 2 hr at room temperature. Subsequently, each of the test liquids, namely PBS, F4H5 or the Rinsing Solution, was used to rinse out the emulsified droplets from inside the model eye chambers. Any remaining liquid in the model after rinsing was dried inside an oven at 37°C for 1 hr. After that, PBS was used to rinse the eye models once again. The washing was then collected and diluted four times to increase the sample volume. The number and the size of the droplets within the washing were quantified using the Coulter Counter. The number of droplets presented in the result section reflected the number of droplets within 1 ml of the diluted sample. The size distribution measurement for each sample presented herein was a mean value of 10 consecutive measurements. The sample size of each group was 4.
The study of the ability and stability to form double emulsion
We tested the ability of three liquids, namely PBS, F4H5 and the Rinsing Solution, to form double emulsions when mixed with the stabilized SO/W emulsion. The mixtures were examined in 48-well culture plates by optical microscopy. The stability of the double emulsion formed by the mixing of SO/ W emulsion and the Rinsing Solution was measured and quantified using a previously described method based on the phenomenon of electro-coalescence (Liu et al. 2015) . Briefly, two Aqueous droplets were slowly injected into the Rinsing Solution inside a custom-built device through two opposite metal needles using syringe pumps (Longer Pumps, Baoding, China; Fig. 1 ). The injection of the Aqueous droplets was stopped when they just made contact. A linearly increasing direct current (DC) voltage with a rate of 0.005 V/s was applied (Electrochemical Workstation 660D; CH Instruments, Bee Cave, TX, USA) to the two droplets through the conductive metal needles when they were in contact. The minimum voltage which caused the droplets to coalesce, namely the critical voltage, reflected the stability of the emulsion formed between the Aqueous phase and the non-Aqueous phase of the Rinsing Solution. In the absence of any surfactants, the emulsion droplets coalesced spontaneously, giving a zero critical voltage.
The study of the evaporation rates of the F4H5 and the Rinsing Solution
The evaporation rates of F4H5 and the Rinsing Solution were measured using a method previously described (Chan et al. 2015b ). An electron beam balance (CP225D; Sartorius, Goettingen, Germany) was used to weigh the liquids over time. A millilitre of the testing liquid was added on a 60-mmdiameter culture dish, and the change of mass of the liquid was plotted against time at room temperature of 25°C.
The in vitro study of the cytotoxicity of F4H5 and the Rinsing Solution
The cell viability of two retinal cell lines after a short-term incubation with the testing liquids was quantified using the 'CellTiter96
Ò AQueous Non-radioactive Cell Proliferation (MTS)' assay (Promega, Madison, WI, USA). The two retinal cell lines including rMC-1 (a rat retinal M€ uller cell line; Sarthy et al. 1998 ) and ARPE-19 (a human retinal pigment epithelium cell line; Dunn et al. 1996) were tested. The rMC-1 was maintained in Dulbecco's modified Eagle's medium (DMEM; ThermoFisher, Waltham, MA, USA), and ARPE-19 was maintained in Dulbecco's modified Eagle's medium F-12 (DMEM F-12; Thermofisher). 10% foetal bovine serum (FBS; Thermofisher), 100 U/ml penicillin and 100 lg/ ml streptomycin (Thermofisher) were added to the cell culture medium as supplements. The study was carried out on an in vitro transwell culturing model (Matteucci et al. 2007 ) using the Costar Transwell Ò 24-mm-diameter semipermeable polyester filters (0.4 lm pore size; Corning Inc., New York, NY, USA). The apical side of the filter was coated with purified mouse laminin (Cultrex Ò ; Trevigen, Gaithersburg, MD, USA) with a concentration of 2 lg/cm 2 at 37°C for 4 hr. The cell seeding number of each cell line was 2.5 9 10 4 cells/well. There were four testing groups including Hank's balanced salt solution (HBSS), perfluorohexyloctane (F6H8), F4H5 and the Rinsing Solution. Hank's balanced salt solution (HBSS) was treated as the control in this study. The two cell lines were incubated with 0.3 ml of the various testing agents for 1 hr. Then, all the testing agents were removed from the filters. The cells were incubated with HBSS for a further 4 days. The rMC-1 and ARPE-19 cells of all the groups were then transferred to 10-cm and 6-cm Petri dishes, respectively, for cell culturing for a further 3 days. The MTS assay was then carried out. Each MTS assay was a carried out of three times, and the mean value of the three experiments was taken as the result. Statistical significance was assessed using the statistical test of one-way analysis of variance (ANOVA) followed by the post hoc test Bonferroni test. The p-value <0.05 was considered to be statistically significant. The cell morphologies after the experiments under different testing agents were captured using light microscopic method. All the experiments for each cell line were repeated three times.
Results
The physical properties of the fluids
The viscosity of F4H5 as stated by the manufacturer was 1.05 cSt. We measured the viscosity of the Rinsing Solution as being 1.12 AE 0.03 cSt, which was close to that of F4H5. The addition of the surfactant significantly reduced the interfacial tension with the preoperative intraocular fluid (from 23.51 to 8.14 mN/m; Table 1 ).
Ability to form double emulsion
No double emulsion was observed when mixing stabilized SO/W emulsion with F4H5. Instead, the emulsion and the F4H5 form two distinct phases, an Aqueous phase at the top and a non-Aqueous phase of F4H5 at the bottom (Fig. 2A,B) . Within the Aqueous phase, the dispersed emulsified SO droplets could be clearly seen. There were also some larger F4H5 droplets within the bottom of the Aqueous phase. The F4H5 solution was at the lower phase. In the presence of surfactant, there was clearly a silicone-oil-in-water-in-F4H5 (SO/W/F4H5) double emulsion formed. These large double emulsion droplets floated on top of the F4H5 liquid (Fig. 2C ).
Stability to form double emulsion
The stability of the double emulsion formed by the Rinsing Solution was assessed by the critical voltage measurement based on the phenomenon of electro-coalescence of the droplets. The critical voltage was 1.32 AE 0.09 V, considerably higher than a zero value for droplets without any surfactants.
Effectiveness of the three test liquids at removing the emulsified SO droplets
The effectiveness of the test liquids at removing the emulsified SO droplets was quantified by counting the number of droplets. The number of droplets that remained after flushing with the Rinsing Solution (13 315 AE 4620/ml) was significantly lower than that with the PBS (23 460 AE 7595/ml) and 
F4H5 groups
(42 800 AE 12 495/ml; p < 0.05; Fig. 3 ). In addition, the droplets that remained in the F4H5 group (42 800 AE 12 495/ml) were significantly more than those in the PBS groups (23 460 AE 7595/ml; p < 0.05).
Evaporation rate of F4H5 and the Rinsing Solution
The measured evaporation rates of F4H5 and the Rinsing Solution were 0.415 g/hr (0.324 ml/hr) and 0.411 g/hr (0.321 ml/hr), respectively. The rate of evaporation was almost linear with time, and the two plots for the two liquids virtually overlapped one another (Fig. 4) .
The biocompatibility of the F4H5 and the Rinsing Solution
On Day 7, the viability of both cell lines, namely rMC-1 and ARPE-19 tested against F4H5 (123 AE 13% for rMC-1 and 93 AE 4% for ARPE-19) or the Rinsing Solution (118 AE 2% for rMC-1 and 87 AE 18% for ARPE-19), did not differ significantly from those tested against the control (HBSS; p < 0.05; Fig. 5 ). These results were consistent with the cell morphology results (Fig. 6 ). F6H8 showed a reduction in the number of viable cells. This applied to both cell lines. The number of viable cells (57 AE 16% for rMC-1 and 60 AE 1% for ARPE-19) when compared to those tested against the HBSS control was both statistically significant (p < 0.05; Fig. 5 ). There was no significant reduction in the number of viable cells when F4H5 or Rinsing Solution was compared to HBSS control (Fig. 6 ).
Discussion
Emulsification of SO is implicated in many of the complications associated with SO tamponade (Miller et al. 2014) . For patients who develop raised intraocular pressure (IOP) despite open angles, the blockage of trabecular outflow by SO droplets has been proposed as the mechanism for secondary angle closure (Ichhpujani et al. 2009 ). In patients who developed raised IOP in the presence of long-term SO tamponade, removal of SO usually does not result in a reduction in the raised pressure (Budenz et al. 2001) . Recently, the spectral domain optical coherence tomography (SD-OCT) images also detected putative SO droplets intraretinally, subretinally, under epiretinal membrane and optic nerve head (Errera et al. 2013 ). Whether they have any toxic effect on the retina or whether they lead to unexplained visual loss before and after SO removal remains speculative (Cazabon et al. 2005) . However, patients and surgeons are often frustrated that repeated washout procedures often fail to get rid of symptomatic floaters and their interference to vision.
In previous publications, we have justified the use of a model eye chamber with surface modification to mimic the hydrophilic properties of the human retina (Fawcett et al. 1994) . We have also shown the ability of the Coulter Counter to accurately assess the number of emulsified droplets, cross-referencing the results from this instrument with those from other Fig. 3 . The number of droplets in the diluted washout (per ml) in the eye model after rinsing with the Rinsing Solution, F4H5 and PBS (unpaired t-test; *, significant difference with control PBS; p < 0.05; #, significant difference with F4H5; p < 0.05; Error bar = AESD; n = 4). methods of quantification including laser scatter and microscopy . We have also published on a method generating stable emulsions in vitro that have a similar size and number distribution profile as those found in patients (Chan et al. 2015a ). We tested the three liquids at removing residual oil droplets from a surface-modified eye chamber.
In emulsion science, Bancroft's rule states 'the phase in which an emulsifier is more soluble constitutes the continuous phase' (Bancroft 1913 (Bancroft , 1915 . In the eye, there are many substances that can act as water-soluble surfactants or emulsifiers. Besides albumin, they include proteins, glycoproteins, phospholipids and retinoids. All are more soluble in Aqueous than in SO. The continuous phase is therefore water, and the emulsified droplets seen in patients are SO-in-water droplets. This is obvious when the droplets are large and 'creaming' occurs; thus, the terms 'inverted hypopyon' (Lai et al. 2008) or 'hyperoleon' are sometimes used. We speculated that SO droplets are difficult to remove because they are adherent to the structures within the eye. The presumption is that both the emulsified droplets (coated with proteins) and the eye structures are hydrophilic and thus, they might have an affinity for one another. Equally, it is plausible that the droplets might not be attached but simply dispersed in a thin film of Aqueous. If the latter was correct, then by removing the film of water, such as in a fluid/air procedure, the droplets should be removed. This is simply not borne out clinically. In our study, we purposely dried the model eye chamber by incubating it for 1 hr at 37°C. Despite this, when Aqueous was added, there were many residual droplets resuspended in the PBS, the number of which could be objectively and accurately quantified.
All three tested liquids, PBS, F4H5 and Rinsing Solution, were not equally efficacious at removing droplets. Using F4H5 with the surfactant, double emulsion of SO/W/F4H5 could be formed. We also demonstrated with the electrocoalescence test that the double emulsion formed was relative stable (Liu et al. 2015) . The coalescence voltage of the water-in-F4H5 with 1% PFPE-PEG-PFPE system was much higher (1.32 AE 0.09 V) than other well-known stable emulsion systems such as waterin-paraffin oil with 2% Span 80, a nonionic surfactant (Sigma, St. Louis, MO, USA; 0.8 V), and water-in-paraffin oil with 2% EM 90, a non-ionic siliconebased surfactant (Evonik Industries, Essen, Germany; 1.1 V; Liu et al. 2015) . The formation of a double emulsion of SO/W/F4H5 is consistent with Bancroft's rule. The F4H5 liquid becomes the continuous phase and the emulsion form is that of water in F4H5. It appears that by employing this strategy, more droplets could be removed. More accurately, we should say that fewer droplets were left in the eye model after rinsing and drying using the Rinsing Solution.
The Coulter Counter Multisizer 4 we used can simultaneously count and estimate the size of the residual emulsified droplets. The instrument is calibrated before use. This is achieved using standard microbeads solutions with a known size distribution. The calibration constant (Kd) is then measured and used to construct the scale. The mean calibration constant of 10 runs was confirmed to be AE4% (refer to operator's manual from manufacturer). In terms of the range of sizes measured, the sensitivity depends on the size of the aperture of the probe used. We chose a probe with a range between 1 and 30 lm. This seems to be most relevant to emulsification that we observe clinically with slit-lamp biomicroscopy. There could be other sources of error including protein coating the aperture of the probe or cellular debris. This applies more to biological solutions such as plasma or blood. As this is an in vitro experiment using thoroughly cleansed instruments and laboratory-based liquids and optimal dilutions, the risk of error is minimized. We have not measured the number of SO droplets below 1 lm because this is technically very challenging. Previous publication from our group, however, suggested that there would be a correlation between the number of droplets above 1 lm and below 1 lm .
The electro-coalescence results provide direct evidence that the double O/ W/F4H5 emulsion was stable. In other words, the O/W/F4H5 state was kinetically favoured due to the PFPE-PEG-PFPE and thus, both the oil and Aqueous phases were trapped in the F4H5. As such, the Rinsing Solution is not just a passive rinse. The solution might be actively overcoming the adherence of Aqueous (and any droplets inside the Aqueous) to the retina in order to form the O/W/F4H5 double emulsion. We therefore believed that this represented a good strategy for removing emulsified droplets and our results might have a direct clinical application.
Our study also showed that the use of F4H5 on its own was associated with significantly more rather than fewer droplets. This needs to be accounted for. This might again be explained by the Bancroft's rule. The model eye chamber contained the protein albumin which is more soluble in water than in F4H5. The albumin would act as a stabilizer to promote break-up of F4H5. The Aqueous would then be the continuous phase, and F4H5 would naturally form droplets inside the Aqueous phase. Certainly, when perfluorohexyloctane (F6H8) was used clinically as a tamponade, emulsification was a major clinical problem (Joussen & Wong 2008) . F4H5 is similar to F6H8 in terms of physical properties and has a low viscosity. Our conjecture is that rather than helping, F4H5 is actually creating more emulsified droplets (of F4H5). The increased droplets in our experiments might not just be SO but also F4H5 as well. At present, we cannot prove our conjecture. The Coulter Counter is a particle counter and cannot discriminate between SO or F4H5 droplets. Our experiments did show that after mixing, there were some large F4H5 droplets in the Aqueous phase (Fig. 2B) .
The experiment results give us a hint of how F4H5 with PFPE-PEG-PFPE might work in two ways. Firstly, there might be merit in using the SO solvent F4H5 to dissolve any residual bulk SO globules that have not emulsified. Secondly, the presence of surfactant PFPE-PEG-PFPE would promote double emulsification and be able to entrap the emulsified droplets. This combination of the two mechanisms might be a useful strategy for more complete removal of SO. We are excited that we might have a clinically useful agent but we also realize that the idea is very much conditional on F4H5 together with PFPE-PEG-PFPE being non-toxic to the retina. Although F6H8 has a CE mark as an internal tamponade, there are concerns about its toxicity (Martinez-Reina et al. 2005) . In our in vitro cytotoxicity test, we find that both the cell lines showed a significant decrease in cell viability on Day 7 after the 1-hr exposure to F6H8 in the beginning of the study (Figs 5 and 6 ). This decrease was very distinct from all the other groups including F4H5. In a previous study, F4H5 was found to be most biocompatible among the common semifluorinated alkanes (Mackiewicz et al. 2007 ). The proposed use of the washing agent to remove the emulsified droplets would be a short intraoperative procedure and should not take over 15 min. We therefore study the effect of both F4H5 and PFPE-PEG-PFPE with a short contact (e.g. 1 hr). Our in vitro experiments showed that the cells tolerated both F4H5 and PFPE-PEG-PFPE well for an hour in the viability studies. The evaporation experiments confirmed that F4H5 itself is relatively volatile; therefore, using air or gas tamponade at the end of the operation, small amounts of F4H5 might diffuse out of the eye. Nonetheless, further in vivo and longterm studies are needed before clinical trials. There are of course other choices of surfactant that are similar to PFPE-PEG-PFPE (Holtze et al. 2008) . Nonetheless, we think the proof of principle has been established and is sufficiently encouraging to take us to the next phase of the study.
There are limitations for this study. Although we showed an acceptable biocompatibility with retinal cell lines in vitro, subsequent animal experiments with longer experimental period are needed to verify its safety in vivo. The intention is to use the F4H5-based solution as an intraoperative tool with a very short period of time in vivo; however, we cannot exclude the possible toxicity of the tool after leaving in the eye for a longer period. There were reports showing that residual perfluorocarbon liquids can lead to unexpected complications (Garg & Theventhiran 2012) . Any liquid intended to be used as an intraoperative tool might be left in the eye accidentally due to poor technique. There is no previous study showing the compatibility of the surfactant PFPE-PEG-PFPE we used with the eye tissues. F4H5 now has a CE mark for clinical use. However, the PFPE-PEG-PFPE is a newly introduced material to be used in the surgery. Although the surfactant has been shown to be compatible with cells in vitro (Holtze et al. 2008; Chen et al. 2011) , in vivo experiments are required to further confirm this before the use in clinical practice.
Conclusion
In summary, F4H5 with PFPE-PEG-PFPE might hold promise as an effective agent to remove both bulk SO and emulsified droplets more effectively. Although such an effective rinsing agent could be found, it still remains to be shown whether postoperative complications associated with SO could be prevented or effectively treated once emulsification has occurred.
